Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag246 ↗At a glance
Journal article in The Journal of Immunology, 2026. Written by Souravi Roy and 5 co-authors. Institution: Department of Biochemistry, University of Calcutta, Kolkata, India. Major MEDLINE topics: Interleukin-33, NLR Family, Pyrin Domain-Containing 3 Protein, Suppressor of Cytokine Signaling 1 Protein, Interleukin-1 Receptor-Like 1 Protein. 70 references. Funded by: Department of Biotechnology, Ministry of Science and Technology.
Abstract (original language)
The dynamic interplay between pro- and anti-inflammatory cytokines plays a crucial role in regulating host immune responses. In our earlier study, we showed that Leishmania donovani–induced IL-33 destabilizes host cytokine dynamics by downregulating TNF-α and IL-12 and ensures intramacrophage parasite survival. Another pertinent host favorable proinflammatory cytokine is Il-1β, maturation of which depends on the activation of NLRP3 inflammasome complex. Our present study highlights that independent neutralization of IL-33 and its receptor ST2, resulted in elevated levels of NLRP3 both at messenger RNA and protein levels, along with increased levels of mature IL-1β. Reduced NLRP3 expression during infection was correlated with decreased protein levels of p65, the major subunit of NF-κB transcription factor complex. An unaltered transcript level of p65 in infected macrophages along with reduced protein expression suggested that post-translational modification and ubiquitination-mediated p65 degradation in the presence of IL-33 was found to be driven by the ubiquitin ligase SOCS1. Administration of IL-33–neutralizing antibody in infected mice resulted in enhanced expression of both p65 and NLRP3, along with increased production of TNF-α, IL-12, and IL-1β, suggesting that IL-33 regulates these cytokines through a shared intermediary, p65. Neutralizing IL-33 during infection led to a reduction in SOCS1 expression, and SOCS1 knockdown by targeted short hairpin RNA in infected mice restores p65 levels, reactivates NLRP3 expressions, and reduces parasite burden in the visceral organs. This study highlights the IL-33/SOCS1 pathway as a potential target for host-directed therapeutic strategies aimed at restoring protective immunity during chronic leishmaniasis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, University of Calcutta, Kolkata, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research, Bhopal, India.
ORCID profiles: Anindita Ukil
Funding
- Department of Biotechnology, Ministry of Science and Technology
Cite
APA
Roy, S., Mandal, M., Banerjee, M., Madbhagat, P., Chande, A., & Ukil, A. (2026). Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag246
Vancouver
Roy S, Mandal M, Banerjee M, Madbhagat P, Chande A, Ukil A. Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag246
BibTeX
@article{Roy2026,
author = {Roy, Souravi and Mandal, Mayumi and Banerjee, Madhurima and Madbhagat, Pratibha and Chande, Ajit and Ukil, Anindita},
title = {Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag246}
}
EUVIMED